<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041115</url>
  </required_header>
  <id_info>
    <org_study_id>MICTLAN-2</org_study_id>
    <nct_id>NCT04041115</nct_id>
  </id_info>
  <brief_title>Effect of Non-alcoholic Beer in Cirrhosis</brief_title>
  <acronym>LFN-NAB</acronym>
  <official_title>Effect of a Multifactorial Intervention (Non-alcoholic Beer, Diet and Exercise) on Endothelial Function, Nutritional Status and Quality of Life in Patients With Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The implementation of nutritional strategies targeting several variables at once could
      benefit patients with cirrhosis. Non-alcoholic beer has different compounds derived from hops
      that exert antioxidant, anti-inflammatory and nutritional properties. The aim of this study
      is to evaluate the effect of diet + exercise and non-alcoholic beer on nutritional status,
      endothelial function and quality of life in patients with cirrhosis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">August 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>8 weeks</time_frame>
    <description>improvement in impedance-derived phase angle (PhA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>8 weeks</time_frame>
    <description>improvement in flow-mediated dilation (brachial artery)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial dysfunction</measure>
    <time_frame>8 weeks</time_frame>
    <description>improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in the heterogeneity of gut Microbiota</measure>
    <time_frame>8 weeks</time_frame>
    <description>Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <condition>Nutritional Status</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>personalized nutritional therapy + aerobic exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-alcoholic Beer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>non-alcoholic beer + personalized nutritional therapy + aerobic exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Non-alcoholic beer</intervention_name>
    <description>Treatment consisted of 330ml non-alcoholic beer per day, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.</description>
    <arm_group_label>Non-alcoholic Beer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>Treatment consisted of 330ml of water, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver Cirrhosis of any aetiology (liver biopsy or a combination of clinical and
             biochemical variables plus evidence of portal hypertension); without decompensation
             during the past month; serum creatinine &lt;1.5 mg%; able to attend the appointed visits
             and willing to participate in the study.

        Exclusion Criteria:

          -  Severe concomitant cardiopulmonary diseases; decompensated type 2 Diabetes Mellitus,
             insulin use or proliferative diabetic retinopathy; orthopedic or osteomuscular
             limitations; any type of cancer; primary sclerosing cholangitis and inflammatory bowel
             disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo U. Macías-Rodríguez, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>July 30, 2019</last_update_submitted>
  <last_update_submitted_qc>July 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cirrhosis</keyword>
  <keyword>nutrition</keyword>
  <keyword>sarcopenia</keyword>
  <keyword>non-alcoholic beer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

